PharmGKB summary: acyclovir/ganciclovir pathway.
作者信息
Maillard Maud, Gong Li, Nishii Rina, Yang Jun J, Whirl-Carrillo Michelle, Klein Teri E
机构信息
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
Departments of Biomedical Data Science.
出版信息
Pharmacogenet Genomics. 2022 Jul 1;32(5):201-208. doi: 10.1097/FPC.0000000000000474. Epub 2022 May 30.
Abstract
摘要
相似文献
1
PharmGKB summary: acyclovir/ganciclovir pathway.药物基因组学知识库总结：阿昔洛韦/更昔洛韦途径。
Pharmacogenet Genomics. 2022 Jul 1;32(5):201-208. doi: 10.1097/FPC.0000000000000474. Epub 2022 May 30.
2
[Acyclovir and ganciclovir in the treatment of malignant hematological diseases].
Zhonghua Nei Ke Za Zhi. 1997 May;36(5):349-51.
3
Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.在接受抗淋巴细胞抗体治疗的巨细胞病毒血清学阳性肾移植和肝移植受者中，先进行静脉注射更昔洛韦抢先治疗后，口服阿昔洛韦或更昔洛韦预防巨细胞病毒疾病的疗效。
Transplantation. 1998 Dec 27;66(12):1780-6. doi: 10.1097/00007890-199812270-00036.
4
Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia.
J Infect Dis. 1998 Oct;178(4):1153-7. doi: 10.1086/515673.
5
Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.在巨细胞病毒血清学阳性的肝移植受者中，静脉注射更昔洛韦诱导治疗后，口服更昔洛韦与口服阿昔洛韦用于长期预防巨细胞病毒疾病的随机对照试验。
Transplantation. 2003 Jan 27;75(2):229-33. doi: 10.1097/01.TP.0000040601.60276.96.
6
Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.
Transplant Proc. 1996 Oct;28(5):2811.
7
A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.口服阿昔洛韦与口服更昔洛韦用于高危肾移植受者巨细胞病毒预防的随机前瞻性对照试验。
Transplantation. 1998 Dec 27;66(12):1682-8. doi: 10.1097/00007890-199812270-00019.
8
Ganciclovir for treatment of cytomegalovirus disease.
DICP. 1989 Jan;23(1):85-6. doi: 10.1177/106002808902300123.
9
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.口服更昔洛韦或口服阿昔洛韦预防器官移植受者原发性巨细胞病毒病
Transpl Infect Dis. 2000 Sep;2(3):112-7.
10
Acyclovir- and ganciclovir-induced neurotoxicity.阿昔洛韦和更昔洛韦引起的神经毒性。
Ann Pharmacother. 1998 Jan;32(1):111-3. doi: 10.1345/aph.17135.
引用本文的文献
1
Network Pharmacology-Based Strategy to Explore the Effect and Mechanism of Zhizhu Granule Improving Glucose-Lipid Metabolism in Rats with Metabolic Syndrome.基于网络药理学的策略探索枳术颗粒改善代谢综合征大鼠糖脂代谢的作用及机制
Diabetes Metab Syndr Obes. 2024 Oct 18;17:3833-3846. doi: 10.2147/DMSO.S477410. eCollection 2024.
2
Exploring the Effectiveness of Acyclovir against Ranaviral Thymidine Kinases: Molecular Docking and Experimental Validation in a Fish Cell Line.探索阿昔洛韦对蛙病毒胸苷激酶的有效性：在鱼类细胞系中的分子对接和实验验证
Life (Basel). 2024 Aug 23;14(9):1050. doi: 10.3390/life14091050.
3
The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis.角膜单纯疱疹病毒 1 感染和疱疹性基质性角膜炎的免疫生物学。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0000624. doi: 10.1128/cmr.00006-24. Epub 2024 Jul 30.
Zotero 插件